CO2019000538A2 - Métodos de fitoterapia para la mejora del sueño, la interacción social, la inquietud o preocupación campo de la divulgación - Google Patents
Métodos de fitoterapia para la mejora del sueño, la interacción social, la inquietud o preocupación campo de la divulgaciónInfo
- Publication number
- CO2019000538A2 CO2019000538A2 CONC2019/0000538A CO2019000538A CO2019000538A2 CO 2019000538 A2 CO2019000538 A2 CO 2019000538A2 CO 2019000538 A CO2019000538 A CO 2019000538A CO 2019000538 A2 CO2019000538 A2 CO 2019000538A2
- Authority
- CO
- Colombia
- Prior art keywords
- restlessness
- concern
- methods
- social interaction
- improving sleep
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
Abstract
Se proporcionan métodos para, entre otras cosas, mejorar el sueño, la energía y la interacción social, y reducir la inquietud o preocupación en mamíferos. En una realización, el método incluye administrar un comprimido, cápsula o comprimido oblongo de 190 mg a 3200 mg de composiciones que incluyen extractos de Crateva nurvala, Equisetum arvense, Lindera aggregata y Zea mays a diario
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/619,404 US11213561B2 (en) | 2017-06-09 | 2017-06-09 | Herbal methods for the improvement of sleep, social interaction, concern or worry |
| PCT/AU2017/051326 WO2018223174A1 (en) | 2017-06-09 | 2017-12-01 | Herbal methods for the improvement of sleep, social interaction, concern or worry |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2019000538A2 true CO2019000538A2 (es) | 2019-02-08 |
Family
ID=64562182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2019/0000538A CO2019000538A2 (es) | 2017-06-09 | 2019-01-18 | Métodos de fitoterapia para la mejora del sueño, la interacción social, la inquietud o preocupación campo de la divulgación |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11213561B2 (es) |
| EP (1) | EP3634454A4 (es) |
| JP (1) | JP2020522460A (es) |
| KR (1) | KR102395041B1 (es) |
| CN (1) | CN109475587B (es) |
| AU (1) | AU2017417581B2 (es) |
| BR (1) | BR112019001369A2 (es) |
| CO (1) | CO2019000538A2 (es) |
| IL (1) | IL263691A (es) |
| MX (1) | MX2019000590A (es) |
| PH (1) | PH12018502722A1 (es) |
| SG (1) | SG11201810829RA (es) |
| WO (1) | WO2018223174A1 (es) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7378115B2 (en) * | 2004-08-18 | 2008-05-27 | Biologic Health Solutions Pty Ltd. | Herbal compositions for the prevention or treatment of urinary incontinence and overactive bladder |
| WO2007144778A2 (en) * | 2006-02-22 | 2007-12-21 | Biologic Health Solutions Pty Ltd. | Herbal compositions for the prevention or treatment of a urinary tract infection |
| AU2012394172C1 (en) * | 2011-12-23 | 2020-01-30 | Tracey Anne Seipel | Herbal compositions for the prevention or treatment of urinary incontinence and overactive bladder |
| US9682115B2 (en) * | 2012-04-02 | 2017-06-20 | Seipel Group Pty Ltd | Herbal compositions for the prevention or treatment of benign prostatic hyperplasia and related disorders |
| US10034852B2 (en) * | 2014-06-13 | 2018-07-31 | Centre For Addiction And Mental Health | Methods and compositions addressing depressed mood |
-
2017
- 2017-06-09 US US15/619,404 patent/US11213561B2/en active Active
- 2017-12-01 AU AU2017417581A patent/AU2017417581B2/en active Active
- 2017-12-01 SG SG11201810829RA patent/SG11201810829RA/en unknown
- 2017-12-01 BR BR112019001369-5A patent/BR112019001369A2/pt not_active Application Discontinuation
- 2017-12-01 KR KR1020197000565A patent/KR102395041B1/ko active IP Right Grant
- 2017-12-01 EP EP17912996.0A patent/EP3634454A4/en active Pending
- 2017-12-01 MX MX2019000590A patent/MX2019000590A/es unknown
- 2017-12-01 JP JP2018562361A patent/JP2020522460A/ja active Pending
- 2017-12-01 WO PCT/AU2017/051326 patent/WO2018223174A1/en active Application Filing
- 2017-12-01 CN CN201780044347.8A patent/CN109475587B/zh active Active
-
2018
- 2018-12-13 IL IL263691A patent/IL263691A/en unknown
- 2018-12-21 PH PH12018502722A patent/PH12018502722A1/en unknown
-
2019
- 2019-01-18 CO CONC2019/0000538A patent/CO2019000538A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201810829RA (en) | 2019-01-30 |
| AU2017417581B2 (en) | 2024-06-27 |
| US11213561B2 (en) | 2022-01-04 |
| EP3634454A1 (en) | 2020-04-15 |
| WO2018223174A1 (en) | 2018-12-13 |
| CN109475587A (zh) | 2019-03-15 |
| EP3634454A4 (en) | 2021-03-10 |
| IL263691A (en) | 2019-01-31 |
| US20180353562A1 (en) | 2018-12-13 |
| PH12018502722A1 (en) | 2019-04-15 |
| BR112019001369A2 (pt) | 2019-04-30 |
| AU2017417581A1 (en) | 2019-02-07 |
| KR20200014258A (ko) | 2020-02-10 |
| KR102395041B1 (ko) | 2022-05-09 |
| CN109475587B (zh) | 2022-04-19 |
| JP2020522460A (ja) | 2020-07-30 |
| MX2019000590A (es) | 2019-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2019000099A2 (es) | Composiciones que comprenden cepas bacterianas | |
| CL2018001646A1 (es) | Conjugados de anticuerpos anti-drosophila similar a delta 3 (anti-dll3) y medicamentos para usarse en el tratamiento contra melanoma. (divisional solicitud 201602105) | |
| MX2018013504A (es) | Metodos de fabricacion, composiciones y aplicaciones medicas de productos farmaceuticos de cannabis administrables oralmente. | |
| CL2018003754A1 (es) | Derivado de glucagon, conjugado del mismo, composición que comprende el mismo y uso terapéutico del mismo. | |
| CL2020000632A1 (es) | Composición y método para el tratamiento del autismo. | |
| PE20171138A1 (es) | Modulacion inmunitaria | |
| MX2021015825A (es) | Formulaciones de anticuerpos estables acuosas. | |
| CL2015002677A1 (es) | Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevención de enfermedades o condiciones asociadas con la disfunción mitocondrial. | |
| BR112015027281A8 (pt) | usos de uma população de nanocarreadores sintéticos que são fixados a imunossupressores e composição compreendendo a referida população de nanocarreadores | |
| CL2019002190A1 (es) | Reducción de la viscosidad de formulaciones farmacéuticas que comprende una proteína terapéutica a una concentración de al menos 70 mg/ml, donde la proteína terapéutica no es un anticuerpo (divisional solicitud 201700984) | |
| EA201990032A1 (ru) | Способы и композиции для терапии посредством потенциирования стволовых клеток | |
| MX2021004999A (es) | Administracion de butirato, beta-hidroxibutirato, cannabidiol y compuestos relacionaods en seres humanos. | |
| CL2021000446A1 (es) | Métodos para la normalización del metabolismo de aminoácidos | |
| EA201001285A1 (ru) | Применение 25-oh d3 для воздействия на физиологию мышц человека | |
| AR102780A1 (es) | Composiciones farmacéuticas, su preparación y sus usos | |
| BR112012020989A2 (pt) | composições veterinárias | |
| CL2015003803A1 (es) | Osteopontina lactea de mamifero para mejorar la capacidad de respuesta inmunitaria. | |
| CL2017000578A1 (es) | Tratamiento del cáncer con el inhibidor de la alfa-amilasa en los animales de compañia | |
| CO2019000604A2 (es) | Composición vaginal que comprende una combinación de estrógeno y vitamina d | |
| ES2531412T3 (es) | Composición nutricional que comprende un extracto de manzana y que reduce los síntomas de alergia, especialmente en niños | |
| CO2019000538A2 (es) | Métodos de fitoterapia para la mejora del sueño, la interacción social, la inquietud o preocupación campo de la divulgación | |
| BR112019023437A2 (pt) | Partículas sólidas | |
| CO2018001271A2 (es) | Composición microbiana de microorganismos probióticos | |
| AR108031A1 (es) | Métodos para mejorar la producción de leche mediante la administración de consorcios microbianos | |
| PE20170305A1 (es) | Combinacion sinergistica de paracetamol/celecoxib para el tratamiento de dolor inflamatorio |